About 90 percent of the DNA in the human genome does not encode proteins. Scientists have only just begun to get a glimpse of the critical role that the non-coding genome plays in health and disease. Fadi plans to use his BroadIgnite funding to delve into non-coding elements—including enhancers, which activate the expression of certain genes—in order to find novel therapeutic targets for cancer.